It has been shown that an increase in number of CD8+ T effector memory CD45RA + cells in the peripheral blood and cerebrospinal fluid could potentially serve as a pathognomonic immune marker in AD [27]. The gene discussed is CD8A; the disease is Alzheimer disease.